Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
5.44
0.05 (0.93%)
At close: Aug 18, 2025, 3:59 PM
5.45
0.18%
Pre-market: Aug 19, 2025, 08:29 AM EDT

Aldeyra Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-55.85M -37.54M -62.02M -57.78M
Depreciation & Amortization
249.62K 262.78K 258.71K 264.18K
Stock-Based Compensation
7.97M 5.75M 8.29M 7.11M
Other Working Capital
7.07M -343.25K -2.56M 6.8M
Other Non-Cash Items
-1.49M 339.65K 283.9K 409.47K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
5.91M 861.18K -3.44M 7.44M
Operating Cash Flow
-43.21M -30.33M -56.64M -42.56M
Capital Expenditures
n/a n/a -16.32K -7.81K
Cash Acquisitions
n/a n/a 16.32K n/a
Purchase of Investments
-96.92M n/a -92.94M n/a
Sales Maturities Of Investments
52M 30M 63M n/a
Other Investing Acitivies
n/a n/a -16.32K n/a
Investing Cash Flow
-44.92M 30M -29.95M -7.81K
Debt Repayment
-292.5K -1.04M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -532.95K n/a 4.68M
Financial Cash Flow
-171.42K -1.27M 1.22M 194.5M
Net Cash Flow
-88.3M -1.6M -85.37M 151.93M
Free Cash Flow
-43.21M -30.33M -56.65M -42.56M